Clinical Trials Directory

Trials / Terminated

TerminatedNCT01810640

Pre-recovery Bedside Liver Biopsy in Brain Death Organ Donors

Pre-recovery Percutaneous Biopsy of Livers in Neurological Death Organ Donors - A Pilot Study

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
6 (actual)
Sponsor
Rutgers, The State University of New Jersey · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

This study's objective is to obtain preliminary data to test the hypotheses that percutaneous liver biopsy in brain death donors is safe and provides reliable histological information. Furthermore, that information when disseminated fully and widely many hours before organ recovery would not only decrease economic costs of wasteful recovery of livers that are not ultimately transplanted but also increase transplantation and decrease cold ischemia times of recovered livers.

Conditions

Interventions

TypeNameDescription
PROCEDUREPercutaneous Liver BiopsyUsing a 16 gauge Jamshidi biopsy needle, without image guidance, 3 passes will be completed to obtain core liver biopsies. Biopsies will be placed on wet saline and processed via frozen sample in OCT compound in 5 micron slices and stained with hematoxylin and eosin for microscopic evaluation. Slides will then be digitalized and shared on Donor.net.

Timeline

Start date
2013-02-01
Primary completion
2015-01-01
Completion
2015-02-01
First posted
2013-03-13
Last updated
2015-05-13

Locations

2 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT01810640. Inclusion in this directory is not an endorsement.